Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11998537 Substituted indole dimer compounds

Patent 11998537 was granted and assigned to Bristol-Myers Squibb Company on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Bristol-Myers Squibb Company

0

Current Assignee

Bristol-Myers Squibb Company

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Alaric J. Dyckman0

Brian K. Whiteley0

John L. Gilmore0

Date of Patent

June 4, 2024

0

Patent Application Number

172877350

Date Filed

October 22, 2019

0

Patent Citations

US Patent 9126999 Tetrahydropyrazolopyrimidine compounds

0

US Patent 9241991 Agents, compositions, and methods for treating pruritus and related skin conditions

0

US Patent 9353115 Immune system modulators

0

US Patent 9376398 Carboxylic acid compounds

0

US Patent 9643967 Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors

0

US Patent 9428495 Selectively substituted quinoline compounds

0

US Patent 6867200 (Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors

0

US Patent 7410975 Small molecule toll-like receptor (TLR) antagonists

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11998537 Substituted indole dimer compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool